These studies concern—to a large extent—IL-1β, IL-6 and TNFα whose elevated levels in blood occur in patients with depression and in situations of mobilization due to chronic stress, anxiety and inflammatory diseases. This evidence concerns the gene IL1B and depressive symptom measurement.